FDA Investigator Gerald Feldman
Gerald Feldman has conducted inspections on 1 sites in 1 countries as of 02 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
1
Last Inspection Date:
02 May 2024
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Gerald Feldman:
Andrea A Branche,
Andrea George, PhD,
Angel K Sandhu,
Anh M Lac,
Barbara J Wilcox, PhD,
Calvin B Koerner,
Carl Lee,
Carole L Jones,
Christopher R Czajka,
Daniel J Roberts,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dustin R Abaonza,
Emily Shacter,
Eric L Dong, BS,
Gerald M Feldman, PhD,
Henry K Lau,
James R Evans,
Jeanne Fringer, PhD,
Jeffrey M Watson,
Joan T Briones,
Joey V Quitania,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joshua S Hunt,
Kevin P Foley,
Lakisha M Williams,
Lance Mde Souza, MBA,
Laurie P Norwood,
LCDR Jennifer H Rhyu,
Linh Tu,
Mabel M Lee,
Maida Henesian (NMI),
Marie K Kinkade,
Mariza M Jafary,
Marsha W Major,
Michael Shanks, MS,
Michael T Cyrus,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Min Shanmabel Liu,
Nayan J Patel,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Omotunde O Osunsanmi,
Peter E Baker,
Peter Kessler, PhD,
Raymond T Oji,
Rebecca Rodriguez,
Rebecca T Davis,
Riley C Myers, PhD,
Robert D Tollefsen,
Sandra S Saniga,
Scott N Lim,
Serge L Beaucage,
Sheilyn H Huang,
Shelley H Beausoleil,
Sherri J Jackson,
Sidney B Priesmeyer,
Stephanie A Slater, MS,
Stuart W Russell,
Thea C Grome,
Thuy T Nguyen, LCDR,
Timothy C Grome,
Truong Xuan Nguyen (Andy),
Walden H Lee,
William V Millar,
Yi Wang, PhD
Gerald Feldman's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2000 | FDA 483 Response | Genentech, Inc. - Form 483R, 2001-01-08 |
August, 2000 | FDA 483 | Genentech, Inc. - Form 483, 2000-08-24 |
August, 2000 | EIR | Genentech, Inc. - EIR, 2000-08-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more